Literature DB >> 15492562

Patterns of initial recurrence in completely resected gastric adenocarcinoma.

Michael D'Angelica1, Mithat Gonen, Murray F Brennan, Alan D Turnbull, Manjit Bains, Martin S Karpeh.   

Abstract

OBJECTIVE: To review recurrence patterns in completely resected gastric adenocarcinoma. SUMMARY BACKGROUND DATA: Despite improvements in the surgical treatment of gastric adenocarcinoma, recurrence rates remain high in patients with advanced stage disease. Understanding the timing and patterns of recurrence is essential to develop effective adjuvant treatment strategies.
METHODS: A retrospective review of a prospectively maintained gastric cancer database was carried out. The timing and pattern of recurrence were reviewed. Univariate and multivariate analyses were performed to identify factors predictive of recurrence patterns.
RESULTS: From July 1985 through June 2000, 1172 patients underwent an R0 resection. Of these, 496 (42%) had recurrence and complete data on recurrence could be obtained in 367 patients (74%). Among the documented recurrences, 79% were detected within 2 years of operation. Locoregional sites were involved as any part of the recurrence pattern in 199 patients (54%). Distant sites were involved as any part of the recurrence in 188 patients (51%) and peritoneal recurrence was detected as any part of the recurrence in 108 patients (29%). On multivariate analysis, peritoneal recurrence was associated with female gender, advanced T-stage, and distal and diffuse type tumors; locoregional recurrence was associated with male gender and proximal location; distant recurrence was associated with proximal location, early T stage, and intestinal type tumors. The median time to death from the time of recurrence was 6 months.
CONCLUSIONS: Recurrence after complete resection of gastric adenocarcinoma usually occurs within 2 years and is rapidly fatal. Patterns of recurrence are variable and may be associated with specific clinicopathologic factors.

Entities:  

Mesh:

Year:  2004        PMID: 15492562      PMCID: PMC1356486          DOI: 10.1097/01.sla.0000143245.28656.15

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

2.  A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach.

Authors:  G McNEER; H VANDENBERG; F Y DONN; L BOWDEN
Journal:  Ann Surg       Date:  1951-07       Impact factor: 12.969

3.  ANALYSIS OF ONE HUNDRED AND SEVENTY-SIX CASES OF CARCINOMA OF THE STOMACH SUBMITTED TO AUTOPSY.

Authors:  M Warwick
Journal:  Ann Surg       Date:  1928-08       Impact factor: 12.969

Review 4.  Surgery for gastric cancer: the American view.

Authors:  M F Brennan; M S Karpeh
Journal:  Semin Oncol       Date:  1996-06       Impact factor: 4.929

Review 5.  Gastric adenocarcinoma.

Authors:  B J Dupont; I Cohn
Journal:  Curr Probl Cancer       Date:  1980-02       Impact factor: 3.187

6.  Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Cancer of the stomach. A patient care study by the American College of Surgeons.

Authors:  H J Wanebo; B J Kennedy; J Chmiel; G Steele; D Winchester; R Osteen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

9.  A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

Authors:  C S Robertson; S C Chung; S D Woods; S M Griffin; S A Raimes; J T Lau; A K Li
Journal:  Ann Surg       Date:  1994-08       Impact factor: 12.969

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  228 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

Review 2.  Liver resections in metastatic gastric cancer.

Authors:  Sid P Kerkar; Clinton D Kemp; Itzhak Avital
Journal:  HPB (Oxford)       Date:  2010-11       Impact factor: 3.647

Review 3.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 4.  Modern imaging techniques for preoperative detection of distant metastases in gastric cancer.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

5.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

6.  Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis.

Authors:  Zhaolun Cai; Yiqiong Yin; Yuan Yin; Chaoyong Shen; Jian Wang; Xiaonan Yin; Zhixin Chen; Ye Zhou; Bo Zhang
Journal:  Gastric Cancer       Date:  2018-05-04       Impact factor: 7.370

7.  Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma.

Authors:  Jun H Lee; Kevin K Chang; Changhwan Yoon; Laura H Tang; Vivian E Strong; Sam S Yoon
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

8.  False-positive findings for tumor markers after curative gastrectomy for gastric cancer.

Authors:  Takao Ohtsuka; Seiji Sato; Yoshihiko Kitajima; Masayuki Tanaka; Yuji Nakafusa; Kohji Miyazaki
Journal:  Dig Dis Sci       Date:  2007-05-03       Impact factor: 3.199

9.  Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer.

Authors:  A Díaz de Liaño; C Yárnoz; C Artieda; R Aguilar; S Viana; A Artajona; H Ortiz
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

10.  Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study.

Authors:  Meng-Long Zhou; Gui-Chao Li; Wang Yang; Wei-Juan Deng; Ran Hu; Yan Wang; Zi-Wen Long; Xiao-Wen Liu; Ya-Nong Wang; Zhen Zhang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.